Prevention and treatment of thrombosis associated with central venous catheters in cancer patients

References

• McGee DC, Gould MK. Preventing complications of central venous catheterization. N Engl J Med 2003;348(12):1123-33
   PubMed Web of Science ®Google Scholar
• Kucher N. Clinical practice. Deep-vein thrombosis of the upper extremities. N Engl J Med 2011;364(9):861-9
   PubMed Web of Science ®Google Scholar
• Chopra V, Anand S, Hickner A, et al. Risk of venous thromboembolism associated with peripherally inserted central catheters: a systematic review and meta-analysis. Lancet 2013;382(9889):311-25
   PubMed Web of Science ®Google Scholar
• Lee AY, Levine MN, Butler G, et al. Incidence, risk factors, and outcomes of catheter-related thrombosis in adult patients with cancer. J Clin Oncol 2006;24(9):1404-8
   PubMed Web of Science ®Google Scholar
• Napalkov P, Felici DM, Chu LK, et al. Incidence of catheter-related complications in patients with central venous or hemodialysis catheters: a health care claims database analysis. BMC Cardiovasc Disord 2013;13:86
   PubMed Web of Science ®Google Scholar
• Evans RS, Sharp JH, Linford LH, et al. Risk of symptomatic DVT associated with peripherally inserted central catheters. Chest 2010;138(4):803-10
   PubMed Web of Science ®Google Scholar
• Baskin JL, Pui CH, Reiss U, et al. Management of occlusion and thrombosis associated with long-term indwelling central venous catheters. Lancet 2009;374(9684):159-69
   PubMed Web of Science ®Google Scholar
• Shivakumar SP, Anderson DR, Couban S. Catheter-associated thrombosis in patients with malignancy. J Clin Oncol 2009;27(29):4858-64
   PubMed Web of Science ®Google Scholar
• Tesselaar ME, Ouwerkerk J, Nooy MA, et al. Risk factors for catheter-related thrombosis in cancer patients. Eur J Cancer 2004;40(15):2253-9
   PubMed Web of Science ®Google Scholar
• Anderson AJ, Krasnow SH, Boyer MW, et al. Thrombosis: the major Hickman catheter complication in patients with solid tumor. Chest 1989;95(1):71-5
   PubMed Web of Science ®Google Scholar
• Blom JW, Osanto S, Rosendaal FR. The risk of a venous thrombotic event in lung cancer patients: higher risk for adenocarcinoma than squamous cell carcinoma. J Thromb Haemost 2004;2(10):1760-5
   PubMed Web of Science ®Google Scholar
• Verso M, Agnelli G, Kamphuisen PW, et al. Risk factors for upper limb deep vein thrombosis associated with the use of central vein catheter in cancer patients. Intern Emerg Med 2008;3(2):117-22
   PubMed Web of Science ®Google Scholar
• Chew HK, Wun T, Harvey D, et al. Incidence of venous thromboembolism and its effect on survival among patients with common cancers. Arch Intern Med 2006;166(4):458-64
   PubMed Web of Science ®Google Scholar
• Piran S, Ngo V, McDiarmid S, et al. Incidence and risk factors of symptomatic venous thromboembolism related to implanted ports in cancer patients. Thromb Res 2014;133(1):30-3
   PubMed Web of Science ®Google Scholar
• Patel GS, Jain K, Kumar R, et al. Comparison of peripherally inserted central venous catheters (PICC) versus subcutaneously implanted port-chamber catheters by complication and cost for patients receiving chemotherapy for non-haematological malignancies. Support Care Cancer 2014;22(1):121-8
   PubMed Web of Science ®Google Scholar
• Saber W, Moua T, Williams EC, et al. Risk factors of catheter-related thrombosis (CRT) in cancer patients: a patient-level data (IPD) meta-analysis of clinical trials and prospective studies. J Thromb Haemost 2011;9(2):312-90
   PubMed Web of Science ®Google Scholar
• Revel-Vilk S, Yacobovich J, Tamary H, et al. Risk factors for central venous catheter thrombotic complications in children and adolescents with cancer. Cancer 2010;116(17):4197-205
   PubMed Web of Science ®Google Scholar
• Richters A, van Vliet M, Peer PG, et al. Incidence of and risk factors for persistent gram-positive bacteraemia and catheter-related thrombosis in haematopoietic stem cell transplantation. Bone Marrow Transplant 2014;49(2):264-9
   PubMed Web of Science ®Google Scholar
• Eastridge BJ, Lefor AT. Complications of indwelling venous access devices in cancer patients. J Clin Oncol 1995;13(1):233-8
   PubMed Web of Science ®Google Scholar
• van Rooden CJ, Schippers EF, Barge RM, et al. Infectious complications of central venous catheters increase the risk of catheter-related thrombosis in hematology patients: a prospective study. J Clin Oncol 2005;23(12):2655-60
   PubMed Web of Science ®Google Scholar
• Linenberger ML. Catheter-related thrombosis: risks, diagnosis, and management. J Natl Compr Canc Netw 2006;4(9):889-901
   PubMedGoogle Scholar
• Haddad TC, Greeno EW. Chemotherapy-induced thrombosis. Thromb Res 2006;118(5):555-68
   PubMed Web of Science ®Google Scholar
• Grant JD, Stevens SM, Woller SC, et al. Diagnosis and management of upper extremity deep-vein thrombosis in adults. Thromb Haemost 2012;108(6):1097-108
   PubMed Web of Science ®Google Scholar
• Mustafa BO, Rathbun SW, Whitsett TL, Raskob GE. Sensitivity and specificity of ultrasonography in the diagnosis of upper extremity deep vein thrombosis: a systematic review. Arch Intern Med 2002;162(4):401-4
   PubMedGoogle Scholar
• Bates SM, Jaeschke R, Stevens SM, et al. Diagnosis of DVT: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 2012;141(2 Suppl):e351S-418S
   PubMed Web of Science ®Google Scholar
• Constans J, Salmi LR, Sevestre-Pietri MA, et al. A clinical prediction score for upper extremity deep venous thrombosis. Thromb Haemost 2008;99(1):202-7
   PubMed Web of Science ®Google Scholar
• Kleinjan A, Di Nisio M, Beyer-Westendorf J, et al. Safety and feasibility of a diagnostic algorithm combining clinical probability, d-Dimer testing, and ultrasonography for suspected upper extremity deep venous thrombosis: a prospective management study. Ann Intern Med 2014;160(7):451-7
   PubMed Web of Science ®Google Scholar
• Bern MM, Lokich JJ, Wallach SR, et al. Very low doses of warfarin can prevent thrombosis in central venous catheters. A randomized prospective trial. Ann Intern Med 1990;112(6):423-8
   PubMed Web of Science ®Google Scholar
• Monreal M, Alastrue A, Rull M, et al. Upper extremity deep venous thrombosis in cancer patients with venous access devices – prophylaxis with a low molecular weight heparin (Fragmin). Thromb Haemost 1996;75(2):251-3
   PubMed Web of Science ®Google Scholar
• Boraks P, Seale J, Price J, et al. Prevention of central venous catheter associated thrombosis using minidose warfarin in patients with haematological malignancies. Br J Haematol 1998;101(3):483-6
   PubMed Web of Science ®Google Scholar
• Ratcliffe M, Broadfoot C, Davidson M, et al. Thrombosis, markers of thrombotic risk, indwelling central venous catheters and antithrombotic prophylaxis using low-dose warfarin in subjects with malignant disease. Clin Lab Haematol 1999;21(5):353-7
   PubMedGoogle Scholar
• Heaton DC, Han DY, Inder A. Minidose (1 mg) warfarin as prophylaxis for central vein catheter thrombosis. Intern Med J 2002;32(3):84-8
   PubMed Web of Science ®Google Scholar
• Magagnoli M, Masci G, Castagna L, et al. Prophylaxis of central venous catheter-related thrombosis with minidose warfarin in patients treated with high-dose chemotherapy and peripheral-blood stem-cell transplantation: retrospective analysis of 228 cancer patients. Am J Hematol 2006;81(1):1-4
   PubMed Web of Science ®Google Scholar
• Couban S, Goodyear M, Burnell M, et al. Randomized placebo-controlled study of low-dose warfarin for the prevention of central venous catheter-associated thrombosis in patients with cancer. J Clin Oncol 2005;23(18):4063-9
   PubMed Web of Science ®Google Scholar
• Verso M, Agnelli G, Bertoglio S, et al. Enoxaparin for the prevention of venous thromboembolism associated with central vein catheter: a double-blind, placebo-controlled, randomized study in cancer patients. J Clin Oncol 2005;23(18):4057-62
   PubMed Web of Science ®Google Scholar
• Karthaus M, Kretzschmar A, Kroning H, et al. Dalteparin for prevention of catheter-related complications in cancer patients with central venous catheters: final results of a double-blind, placebo-controlled phase III trial. Ann Oncol 2006;17(2):289-96
   PubMed Web of Science ®Google Scholar
• Niers TM, Di Nisio M, Klerk CP, et al. Prevention of catheter-related venous thrombosis with nadroparin in patients receiving chemotherapy for hematologic malignancies: a randomized, placebo-controlled study. J Thromb Haemost 2007;5(9):1878-82
   PubMed Web of Science ®Google Scholar
• Abdelkefi A, Ben Othman T, Kammoun L, et al. Prevention of central venous line-related thrombosis by continuous infusion of low-dose unfractionated heparin, in patients with haemato-oncological disease. A randomized controlled trial. Thromb Haemost 2004;92(3):654-61
   PubMed Web of Science ®Google Scholar
• Mismetti P, Mille D, Laporte S, et al. Low-molecular-weight heparin (nadroparin) and very low doses of warfarin in the prevention of upper extremity thrombosis in cancer patients with indwelling long-term central venous catheters: a pilot randomized trial. Haematologica 2003;88(1):67-73
   PubMed Web of Science ®Google Scholar
• De Cicco M, Matovic M, Balestreri L, et al. Early and short-term acenocumarine or dalteparin for the prevention of central vein catheter-related thrombosis in cancer patients: a randomized controlled study based on serial venographies. Ann Oncol 2009;20(12):1936-42
   PubMed Web of Science ®Google Scholar
• Lavau-Denes S, Lacroix P, Maubon A, et al. Prophylaxis of catheter-related deep vein thrombosis in cancer patients with low-dose warfarin, low molecular weight heparin, or control: a randomized, controlled, phase III study. Cancer Chemother Pharmacol 2013;72(1):65-73
   PubMed Web of Science ®Google Scholar
• Young AM, Billingham LJ, Begum G, et al. Warfarin thromboprophylaxis in cancer patients with central venous catheters (WARP): an open-label randomised trial. Lancet 2009;373(9663):567-74
   PubMed Web of Science ®Google Scholar
• Akl EA, Vasireddi SR, Gunukula S, et al. Anticoagulation for patients with cancer and central venous catheters. Cochrane Database Syst Rev 2011(4):CD006468
   Web of Science ®Google Scholar
• Kahn SR, Lim W, Dunn AS, et al. Prevention of VTE in nonsurgical patients: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 2012;141(2 Suppl):e195S-226S
   PubMed Web of Science ®Google Scholar
• Schiffer CA, Mangu PB, Wade JC, et al. Central venous catheter care for the patient with cancer: American Society of Clinical Oncology clinical practice guideline. J Clin Oncol 2013;31(10):1357-70
   PubMed Web of Science ®Google Scholar
• Debourdeau P, Farge D, Beckers M, et al. International clinical practice guidelines for the treatment and prophylaxis of thrombosis associated with central venous catheters in patients with cancer. J Thromb Haemost 2013;11(1):71-80
   PubMed Web of Science ®Google Scholar
• Mandala M, Labianca R; European Society for Medical Oncology. Venous thromboembolism (VTE) in cancer patients. ESMO clinical recommendations for prevention and management. Thromb Res 2010;125(Suppl 2):S117-19
   PubMed Web of Science ®Google Scholar
• Debourdeau P, Kassab Chahmi D, Le Gal G, et al. 2008 SOR guidelines for the prevention and treatment of thrombosis associated with central venous catheters in patients with cancer: report from the working group. Ann Oncol 2009;20(9):1459-71
   PubMed Web of Science ®Google Scholar
• Streiff MB, Bockenstedt PL, Cataland SR, et al. Venous thromboembolic disease. J Natl Compr Canc Netw 2013;11(11):1402-29
   PubMed Web of Science ®Google Scholar
• Enden T, Klow NE, Sandvik L, et al. Catheter-directed thrombolysis vs. anticoagulant therapy alone in deep vein thrombosis: results of an open randomized, controlled trial reporting on short-term patency. J Thromb Haemost 2009;7(8):1268-75
   PubMed Web of Science ®Google Scholar
• Schindler J, Bona RD, Chen HH, et al. Regional thrombolysis with urokinase for central venous catheter-related thrombosis in patients undergoing high-dose chemotherapy with autologous blood stem cell rescue. Clin Appl Thromb Hemost 1999;5(1):25-9
   PubMed Web of Science ®Google Scholar
• Pucheu A, Dierhas M, Leduc B, et al. Fibrinolysis of deep venous thrombosis on implantable perfusion devices. Apropos of a consecutive series of 57 cases of thrombosis and 32 cases of fibrinolysis. Bull Cancer 1996;83(4):293-9
   PubMed Web of Science ®Google Scholar
• Kim HS, Preece SR, Black JH, et al. Safety of catheter-directed thrombolysis for deep venous thrombosis in cancer patients. J Vasc Surg 2008;47(2):388-94
   PubMed Web of Science ®Google Scholar
• Kovacs MJ, Kahn SR, Rodger M, et al. A pilot study of central venous catheter survival in cancer patients using low-molecular-weight heparin (dalteparin) and warfarin without catheter removal for the treatment of upper extremity deep vein thrombosis (The Catheter Study). J Thromb Haemost 2007;5(8):1650-3
   PubMed Web of Science ®Google Scholar
• Rathbun SW, Stoner JA, Whitsett TL. Treatment of upper-extremity deep vein thrombosis. J Thromb Haemost 2011;9(10):1924-30
   PubMed Web of Science ®Google Scholar
• A Pilot Study in Cancer Patients With Central Line Associated Blood Clots in the Upper Extremity Treated With Rivaroxaban (Catheter 2). Available from: http://clinicaltrials.gov/show/NCT01708850
   Google Scholar
• Kearon C, Akl EA, Comerota AJ, et al. Antithrombotic therapy for VTE disease: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 2012;141(2 Suppl):e419S-94S
   PubMed Web of Science ®Google Scholar
• Frank DA, Meuse J, Hirsch D, et al. The treatment and outcome of cancer patients with thromboses on central venous catheters. J Thromb Thrombolysis 2000;10(3):271-5
   PubMed Web of Science ®Google Scholar
• Tran H, Arellano M, Chamsuddin A, et al. Deep venous thromboses in patients with hematological malignancies after peripherally inserted central venous catheters. Leuk Lymphoma 2010;51(8):1473-7
   PubMed Web of Science ®Google Scholar
• Owens CA, Bui JT, Knuttinen MG, et al. Pulmonary embolism from upper extremity deep vein thrombosis and the role of superior vena cava filters: a review of the literature. J Vasc Interv Radiol 2010;21(6):779-87
   PubMed Web of Science ®Google Scholar
• Munoz FJ, Mismetti P, Poggio R, et al. Clinical outcome of patients with upper-extremity deep vein thrombosis: results from the RIETE Registry. Chest 2008;133(1):143-8
   PubMed Web of Science ®Google Scholar
• Witt DM, Delate T, Garcia DA, et al. Risk of thromboembolism, recurrent hemorrhage, and death after warfarin therapy interruption for gastrointestinal tract bleeding. Arch Intern Med 2012;172(19):1484-91
   PubMedGoogle Scholar
• Hawryluk GW, Austin JW, Furlan JC, et al. Management of anticoagulation following central nervous system hemorrhage in patients with high thromboembolic risk. J Thromb Haemost 2010;8(7):1500-8
   PubMed Web of Science ®Google Scholar
• Lechner D, Wiener C, Weltermann A, et al. Comparison between idiopathic deep vein thrombosis of the upper and lower extremity regarding risk factors and recurrence. J Thromb Haemost 2008;6(8):1269-74
   PubMed Web of Science ®Google Scholar
• Flinterman LE, van Hylckama Vlieg A, Rosendaal FR, Doggen CJ. Recurrent thrombosis and survival after a first venous thrombosis of the upper extremity. Circulation 2008;118(13):1366-72
   PubMed Web of Science ®Google Scholar
• Kumar V, Abbas AK, Fausto N, Mitchell R. Robbins basic pathology. Elsevier Ltd; Oxford, UK: 2007. Available from: www.studentconsult.com
   Google Scholar
• Savage KJ, Wells PS, Schulz V, et al. Outpatient use of low molecular weight heparin (Dalteparin) for the treatment of deep vein thrombosis of the upper extremity. Thromb Haemost 1999;82(3):1008-10
   PubMed Web of Science ®Google Scholar